- Home
- RAPT vs SXC Comparison
RAPT vs SXC Comparison
Compare RAPT & SXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RAPT | SXC |
|---|---|---|
| Founded | 2015 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 498.4M | 549.5M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | RAPT | SXC |
|---|---|---|
| Price | $35.21 | $7.88 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 1 |
| Target Price | ★ $57.00 | $10.00 |
| AVG Volume (30 Days) | 365.9K | ★ 1.2M |
| Earning Date | 03-05-2026 | 01-30-2026 |
| Dividend Yield | N/A | ★ 6.07% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.75 |
| Revenue | N/A | ★ $1,843,100,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.94 |
| P/E Ratio | ★ N/A | $10.55 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.67 | $6.24 |
| 52 Week High | $42.39 | $10.52 |
Technical Indicators
Market Signals| Indicator | RAPT | SXC |
|---|---|---|
| Relative Strength Index (RSI) | 55.37 | 59.79 |
| Support Level | $33.01 | $7.47 |
| Resistance Level | $35.42 | $8.33 |
| Average True Range (ATR) | 2.17 | 0.24 |
| MACD | 0.03 | 0.05 |
| Stochastic Oscillator | 83.95 | 64.29 |
Price Performance
Historical ComparisonAbout RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About SXC SunCoke Energy Inc.
SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is primarily used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through three segments: Domestic Coke, Brazil Coke, and Logistics. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.